Clinical Trials Using Autologous TP53 R175H Mutant-specific HLA-A*02:01-restricted TCR Gene Engineered T-lymphocytes NT-175
Review the clinical trials studying autologous tp53 r175h mutant-specific hla-a*02:01-restricted tcr gene engineered t-lymphocytes nt-175 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-1 of
1